Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction - the ILO-HOPE Clinical Trial

NCT03620526 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03620526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction - the ILO-HOPE Clinical Trial
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 29, 2017
Completion date
January 1, 2020
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with normal ejection fraction